Options Trading News

January 18, 2013  Fri 7:35 AM CT


Profit Comes in Better Than Expected

Morgan Stanley reported fourth-quarter earnings of $0.28 a share, beating the $0.27 average analyst forecast. Revenue missed expectations, but investors are focusing on that profit number, sending MS up by more than 6 percent before the bell on my tradeMONSTER platform.

FDA Approves Migraine Skin Patch

NuPath announced late yesterday that the Food & Drug Administration approved its Zecuity skin patch for the treatment of migraines, making it the first such product on the market. PATH rallies 19 percent on the news.

Research in Motion Keeps Moving

Research in Motion keeps moving! Today, it was upgraded to "buy" from "hold" at Jefferies, which cited the possibility of its Blackberry mail being able to work on iPhones and Android devices. The target price was raised to $19.50 from $13. RIMM is up 7 percent in the premarket.

Capital One Drops on Earnings Miss

Capital One earned just $1.41 a share in the fourth quarter on revenue of $5.62 billion. Analysts had expected $1.58 and $5.71 billion, respectively. Those results have COF down 7 percent in early trading.

Share this article with your friends

Related Stories


Put buying targets Morgan Stanley

November 16, 2015

The investment firm has pulled back since rallying along with other financial names on speculation that the Federal Reserve would raise interest rates in December.


Morgan Stanley seen holding firm

November 10, 2015

The financial firm is down 9.5 percent on the year but has gained 7.3 percent in the last month on rising speculation that the Federal Reserve will hike interest rates.


Premium Services

Education & Strategy

In Real Estate It's All About Location!

Location, location, location... that's what they say in Real Estate. Well, if that is true, then in the stock market it's timing, timing, timing!

View more education articles »